封面
市場調查報告書
商品編碼
1578279

全球自體免疫疾病診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 231 Pages | 商品交期: 最快1-2個工作天內

價格

全球自體免疫疾病診斷市場需求預計將從 2023 年的 132 億美元達到 2032 年近 193.5 億美元的市場規模,2024-2032 年研究期間複合年成長率為 4.34%。

免疫系統可以保護身體免受許多細菌、病毒感染和其他疾病的侵害。自體免疫疾病是體內發生的一種不尋常的免疫反應。自體免疫疾病會降低人體抵抗外來顆粒的能力,進而導致攻擊自身組織。自體免疫疾病在女性中比男性更常見。克隆氏症、類風濕性關節炎、發炎性腸道疾病、多發性硬化症、系統性紅斑狼瘡是自體免疫疾病的一些例子。一些醫療中心有許多商業測試可用於診斷自體免疫疾病。

市場動態

由於政府資助的增加以及診所和診斷中心的合作,全球自體免疫疾病診斷市場預計將成長。除此之外,類風濕性關節炎、格雷夫茲病和橋本甲狀腺病等疾病發生率的上升也推動了市場的成長。此外,對各種自體免疫疾病的認知、醫學領域的進步、實驗室技術的改進等也推動了需求。然而,假陽性結果的高可能性和診斷測試結果的緩慢週轉時間可能會阻礙市場成長。此外,新興市場的發展以及用於疾病預後的新型生物標記的進步可能會為市場成長提供新的機會。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球自體免疫疾病診斷市場的各個細分市場進行了包容性評估。自體免疫疾病診斷產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

自體免疫疾病診斷市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按測試類型

  • 抗核抗體測試
  • 自體抗體測試
  • 全血球計數 (CBC)
  • 綜合代謝組
  • C反應蛋白(CRP)測試
  • 紅血球沉降速率 (ESR)
  • 尿液分析
  • 其他

依疾病類型

  • 格雷夫茲病
  • 橋本氏甲狀腺
  • 多發性硬化症
  • 類風濕關節炎
  • 系統性紅斑狼瘡(狼瘡)
  • 1 型糖尿病
  • 其他

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲自體免疫疾病診斷市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。自體免疫疾病診斷市場的主要參與者包括Abbott Laboratories Inc.、Beckman Coulter Inc.、BioMeRieux SA、Bio-Rad Laboratories、F. Hoffmann-La、Roche Ltd.、Inova Diagnostics Inc.、Quest Diagnostics、SQI Diagnostics Inc .。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:自體免疫疾病診斷 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按測試類型進行的市場吸引力分析
    • 按疾病類型分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球自體免疫疾病診斷市場分析:按測試類型

  • 按測試類型概述
  • 按測試類型進行歷史和預測資料分析
  • 抗核抗體測試
  • 自體抗體測試
  • 全血球計數 (CBC)
  • 綜合代謝組
  • C反應蛋白(CRP)測試
  • 紅血球沉降速率 (ESR)
  • 尿液分析
  • 其他

第 6 章:全球自體免疫疾病診斷市場分析:依疾病類型

  • 依疾病類型概述
  • 按疾病類型進行歷史和預測資料分析
  • 格雷夫茲病
  • 橋本氏甲狀腺
  • 多發性硬化症
  • 類風濕關節炎
  • 系統性紅斑狼瘡(狼瘡)
  • 1 型糖尿病
  • 其他

第 7 章:全球自體免疫疾病診斷市場分析:按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章:自體免疫疾病診斷公司的競爭格局

  • 自體免疫疾病診斷市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Beckman Coulter Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioMeRieux SA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Roche Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Inova Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • SQI Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Siemens Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資料和最新進展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR11214429

The global demand for Autoimmune Disease Diagnostics Market is presumed to reach the market size of nearly USD 19.35 Billion by 2032 from USD 13.2 Billion in 2023 with a CAGR of 4.34% under the study period 2024-2032.

The immune system offers protection to the body from many bacterial, viral infections, and other diseases. The autoimmune disorder is an unusual immune response occurring in the body. Autoimmune diseases reduce the body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are many tests commercially available at several healthcare centers to diagnose autoimmune disorders.

MARKET DYNAMICS

The global autoimmune disease diagnostics market is expected to grow due to increased government funding, a collaboration of clinics and diagnostics centers. In addition to this, the rise in the incidence of diseases such as rheumatoid arthritis, Graves, and Hashimoto's thyroid disease drives the growth of the market. Further, awareness about the various autoimmune diseases, advancements in medical fields, improved laboratory techniques, and others are also propelling the demand. However, high chances of false-positive results and slow turnaround time for diagnostic test results may hamper the market growth. Moreover, the developments in an emerging market, advancement in novel biomarkers for the prognosis of diseases are likely to offer new opportunities in market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoimmune Disease Diagnostics. The growth and trends of Autoimmune Disease Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autoimmune Disease Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

  • Antinuclear Antibody Test
  • Autoantibody Test
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-reactive Protein (CRP) Test
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

By Disease Type

  • Graves' Disease
  • Hashimoto's Thyroid its
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • SLE (Lupus)
  • Type 1 Diabetes
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autoimmune Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoimmune Disease Diagnostics market include Abbott Laboratories Inc., Beckman Coulter Inc., BioMeRieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics Inc., Quest Diagnostics, SQI Diagnostics Inc. Siemens Healthcare Among Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AUTOIMMUNE DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By Disease Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

  • 5.1. Overview By Test Type
  • 5.2. Historical and Forecast Data Analysis By Test Type
  • 5.3. Antinuclear Antibody Test Historic and Forecast Sales By Regions
  • 5.4. Autoantibody Test Historic and Forecast Sales By Regions
  • 5.5. Complete Blood Count (CBC) Historic and Forecast Sales By Regions
  • 5.6. Comprehensive Metabolic Panel Historic and Forecast Sales By Regions
  • 5.7. C-reactive Protein (CRP) Test Historic and Forecast Sales By Regions
  • 5.8. Erythrocyte Sedimentation Rate (ESR) Historic and Forecast Sales By Regions
  • 5.9. Urinalysis Historic and Forecast Sales By Regions
  • 5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE

  • 6.1. Overview By Disease Type
  • 6.2. Historical and Forecast Data Analysis By Disease Type
  • 6.3. Graves' Disease Historic and Forecast Sales By Regions
  • 6.4. Hashimoto's Thyroid its Historic and Forecast Sales By Regions
  • 6.5. Multiple Sclerosis Historic and Forecast Sales By Regions
  • 6.6. Rheumatoid Arthritis Historic and Forecast Sales By Regions
  • 6.7. SLE (Lupus) Historic and Forecast Sales By Regions
  • 6.8. Type 1 Diabetes Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE AUTOIMMUNE DISEASE DIAGNOSTICS COMPANIES

  • 8.1. Autoimmune Disease Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Beckman Coulter Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. BioMeRieux SA
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Bio-Rad Laboratories
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. F. Hoffmann-La
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Roche Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Inova Diagnostics Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Quest Diagnostics
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. SQI Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Siemens Healthcare
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Test Type (USD MN)
  • Antinuclear Antibody Test Market Sales By Geography (USD MN)
  • Autoantibody Test Market Sales By Geography (USD MN)
  • Complete Blood Count (CBC) Market Sales By Geography (USD MN)
  • Comprehensive Metabolic Panel Market Sales By Geography (USD MN)
  • C-reactive Protein (CRP) Test Market Sales By Geography (USD MN)
  • Erythrocyte Sedimentation Rate (ESR) Market Sales By Geography (USD MN)
  • Urinalysis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Disease Type (USD MN)
  • Graves' Disease Market Sales By Geography (USD MN)
  • Hashimoto's Thyroid its Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Rheumatoid Arthritis Market Sales By Geography (USD MN)
  • SLE (Lupus) Market Sales By Geography (USD MN)
  • Type 1 Diabetes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Autoimmune Disease Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Autoimmune Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Autoimmune Disease Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Test Type (USD MN)
  • Antinuclear Antibody Test Market Sales By Geography (USD MN)
  • Autoantibody Test Market Sales By Geography (USD MN)
  • Complete Blood Count (CBC) Market Sales By Geography (USD MN)
  • Comprehensive Metabolic Panel Market Sales By Geography (USD MN)
  • C-reactive Protein (CRP) Test Market Sales By Geography (USD MN)
  • Erythrocyte Sedimentation Rate (ESR) Market Sales By Geography (USD MN)
  • Urinalysis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Type (USD MN)
  • Graves' Disease Market Sales By Geography (USD MN)
  • Hashimoto's Thyroid its Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Rheumatoid Arthritis Market Sales By Geography (USD MN)
  • SLE (Lupus) Market Sales By Geography (USD MN)
  • Type 1 Diabetes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.